UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 931

Sortiert nach

Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

Chest, 2009-06, Vol.135 (6), p.1610-1618

2009

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis

Journal of aerosol medicine and pulmonary drug delivery, 2020-02, Vol.33 (1), p.15

2020

Link zum Volltext

Verfügbarkeit prüfen

A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients

Journal of aerosol medicine and pulmonary drug delivery, 2014-12, Vol.27 (6), p.441

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

Chest, 2009-05, Vol.135 (5), p.1223-1232

2009

Link zum Volltext

Verfügbarkeit prüfen

Interstitial Lung Disease: Not So Fast

American journal of respiratory and critical care medicine, 2024-05, Vol.209 (9), p.1173

Montgomery, A Bruce

2024

Link zum Volltext

Verfügbarkeit prüfen

Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis

Pharmaceutical research, 2020-01, Vol.37 (1), p.3-11, Article 3

2020

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial

Chest, 2017-06, Vol.151 (6), p.1239-1246

2017

Link zum Volltext

Verfügbarkeit prüfen

Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores

Thorax, 2015-01, Vol.70 (1), p.12-20

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

American journal of respiratory and critical care medicine, 2008-11, Vol.178 (9), p.921-928

2008

Link zum Volltext

Verfügbarkeit prüfen

Mucin Binding Reduces Colistin Antimicrobial Activity

Antimicrobial agents and chemotherapy, 2015-10, Vol.59 (10), p.5925-5931

2015

Link zum Volltext

Verfügbarkeit prüfen

Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep

Pharmaceutical research, 2023-08, Vol.40 (8), p.1915-1925

2023

Link zum Volltext

Verfügbarkeit prüfen

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

American journal of respiratory and critical care medicine, 2012-01, Vol.185 (2), p.171-178

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy

Antimicrobial agents and chemotherapy, 2017-01, Vol.61 (1)

2017

Link zum Volltext

Verfügbarkeit prüfen

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

Pediatric pulmonology, 2010-11, Vol.45 (11), p.1121-1134

2010

Link zum Volltext

Verfügbarkeit prüfen

Aerosolized antibiotics: do they add to the treatment of pneumonia?

Current opinion in infectious diseases, 2013-12, Vol.26 (6), p.538-544

2013

Link zum Volltext

Verfügbarkeit prüfen

A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis

Chest, 2014-08, Vol.146 (2), p.437-448

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial

Journal of cystic fibrosis, 2013-03, Vol.12 (2), p.130-140

2013

Link zum Volltext

Verfügbarkeit prüfen

Amikacin-Fosfomycin at a Five-to-Two Ratio: Characterization of Mutation Rates in Microbial Strains Causing Ventilator-Associated Pneumonia and Interactions with Commonly Used Antibiotics

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.3708-3713

2014

Link zum Volltext

Verfügbarkeit prüfen

Potentiation Effects of Amikacin and Fosfomycin against Selected Amikacin-Nonsusceptible Gram-Negative Respiratory Tract Pathogens

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.3714-3719

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship

Pulmonary pharmacology & therapeutics, 2020-08, Vol.63 (C), p.101933, Article 101933

2020

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials

American journal of respiratory and critical care medicine, 2013-06, Vol.187 (11), p.1269-1269

2013

Link zum Volltext

Verfügbarkeit prüfen

Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411

Journal of aerosol medicine and pulmonary drug delivery, 2014-06, Vol.27 (3), p.200

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 931

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(713)
Mit Volltextzugriff
(814)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(428)
MEDLINE
(378)
Single Journals
(337)
Journals@Ovid
(310)
IngentaConnect
(300)
IngentaConnect Journals
(123)
Elsevier ScienceDirect Journals Complete
(99)
Wiley Online Library Journals Frontfile Complete
(84)
Wiley Online Library Full Collection 2018
(68)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(57)
eBooks on EBSCOhost
(55)
Ebook Central Perpetual and DDA
(53)
JSTOR
(47)
Nexis Uni
(46)
SpringerLink Journals - AutoHoldings
(42)
Nature
(41)
De Gruyter eBooks
(38)
IEEE Xplore
(36)
Oxford journals
(31)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Against The Grain
(120)
The Australian
(30)
Clinical Cancer Research
(22)
Journal Of Clinical Oncology
(19)
The New England Journal Of Medicine
(19)
Chest
(14)
Urology
(13)
Cancer Research
(12)
Hepatology
(11)
European Urology
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis

A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

Interstitial Lung Disease: Not So Fast

Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial

A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial

Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

Mucin Binding Reduces Colistin Antimicrobial Activity

Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

Aerosolized antibiotics: do they add to the treatment of pneumonia?

A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial

Amikacin-Fosfomycin at a Five-to-Two Ratio: Characterization of Mutation Rates in Microbial Strains Causing Ventilator-Associated Pneumonia and Interactions with Commonly Used Antibiotics

Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study

Potentiation Effects of Amikacin and Fosfomycin against Selected Amikacin-Nonsusceptible Gram-Negative Respiratory Tract Pathogens

Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship

Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials

Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411

Suchergebnisse filtern